ARCHIVES

Faulding, NaPro In Agreement For Marketing Paclitaxel.

This article is from The Cancer Letter archive.

Vol. 27 No. 13 | March 30, 2001

Download PDF Visit The Full Archive

Related Articles

FDA To Issue “Complete Response” Letters To Drug Sponsors.

July 11, 2008

Decline In Breast Cancer Death Explained By Screening, Adjuvant Therapy, Study Finds

November 25, 2005

In Brief: NCAB To Hear NCOG Appeal; FDA Renege On New Toxicology Protocol, Holds Up INDs

April 24, 1981

NCI Plans to Expand R01 Grant Funding By$48 Million, Increase Other Grants Also

February 16, 1996

L.A. County Nears Crucial Decision On Construction Funds

January 7, 1977

At AAAS Meeting, David Baltimore Comments on Bush Administration Science Policy.

March 3, 2006